PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
19,598,975
Share change
-2,633,924
Total reported value
$8,721,000
Price per share
$0.44
Number of holders
28
Value change
-$3,440,801
Number of buys
17
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q4 2016

As of 31 Dec 2016, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,598,975 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, Ion Asset Management Ltd., UBS OCONNOR LLC, FEDERATED INVESTORS INC /PA/, ANGELO GORDON & CO., L.P., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, CITIGROUP INC, RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, and DEUTSCHE BANK AG\. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.